Can apixaban prevent venous thromboembolism better than rivaroxaban?

被引：0
|
作者：
Coleman, Craig I. [1 ,2 ]
Baker, William L. [1 ,2 ]
机构：
[1] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA
[2] Univ Connecticut, Evidence Based Practice Ctr, Storrs, CT 06269 USA
来源：
LANCET HAEMATOLOGY | 2019年 / 6卷 / 04期
关键词：
D O I：
10.1016/S2352-3026(19)30022-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E179 / E179
页数：1
相关论文
共 50 条
  • [41] Apixaban and rivaroxaban in patients with cerebral venous thrombosis
    Covut, Fahrettin
    Kewan, Tariq
    Perez, Oscar
    Flores, Monica
    Haddad, Abdo
    Daw, Hamed
    THROMBOSIS RESEARCH, 2019, 173 : 77 - 78
  • [42] Apixaban for Extended Treatment of Venous Thromboembolism
    Agnelli, Giancarlo
    Buller, Harry R.
    Cohen, Alexander
    Curto, Madelyn
    Gallus, Alexander S.
    Johnson, Margot
    Porcari, Anthony
    Raskob, Gary E.
    Weitz, Jeffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (08): : 699 - 708
  • [43] Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers
    Lagana, Alessandro
    Sorella, Silvia
    Fucci, Ludovica
    Santoro, Cristina
    Ligia, Silvio
    Mormile, Rosaria
    Baldacci, Erminia
    Chistolini, Antonio
    ANNALS OF HEMATOLOGY, 2024, 103 (11) : 4731 - 4739
  • [44] Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism
    Pagenhardt, Justine
    Hayward, Isaac
    Dilcher, Brian
    Quedado, Kimberly
    Kline, Jeffrey
    THROMBOSIS RESEARCH, 2021, 204 : 29 - 31
  • [45] Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data
    Dawwas, Ghadeer K.
    Leonard, Charles E.
    Lewis, James D.
    Cuker, Adam
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (01) : 20 - +
  • [46] Venous thromboembolism - a major health and financial burden: how can we do better to prevent this disease?
    Chong, Beng H.
    Braithwaite, Jeffrey
    Harris, Mark F.
    Fletcher, John P.
    MEDICAL JOURNAL OF AUSTRALIA, 2008, 189 (03) : 134 - 135
  • [47] The Real World Experience Regarding the Safety of Rivaroxaban and Apixaban in Venous Thromboembolism Patients with High Bleeding Risk
    Ouyang, Haoxu
    Khillan, Ratesh
    Yu, Nyein Htway
    Preet, Mohan
    BLOOD, 2019, 134
  • [48] Concerns Regarding the Use of Oral Anticoagulants (Rivaroxaban and Apixaban) for Venous Thromboembolism Prophylaxis in Plastic Surgery Patients
    Swanson, Eric
    AESTHETIC SURGERY JOURNAL, 2016, 36 (08) : NP262 - NP264
  • [49] Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
    Caroti, Kimberly Snow
    Becattini, Cecilia
    Carrier, Marc
    Cohen, Alexander T.
    Ekbom, Anders
    Khorana, Alok A.
    Lee, Agnes Y. Y.
    Brescia, Christopher
    Abdelgawwad, Khaled
    Psaroudakis, George
    Rivera, Marcela
    Schaefer, Bernhard
    Brobert, Gunnar
    Coleman, Craig I.
    TH OPEN, 2023, 07 (03) : e206 - e216
  • [50] Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia
    Almutairi, Abdulaali R.
    Alruthia, Yazed
    Alyami, Majed S.
    Alshaya, Omar A.
    Alanazi, Taif Z.
    Al Daghreer, Sarah I.
    Korayem, Ghazwa B.
    Alrasheed, Sarah A.
    Alorf, Reema A.
    Almohammed, Omar A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2025, 31
12345